Photobiomodulation is not new. It has been used in advanced veterinary rehabilitation centres worldwide for over two decades. Here is what the peer-reviewed evidence says — and why it matters for your clinic.
VetLase is a professional-grade photobiomodulation system designed and manufactured in India, for Indian veterinary clinics. We are not a rebranded import. We are not a consumer device dressed up in clinical language.
We are a manufacturer with a direct relationship with every clinic that uses our devices. When something needs attention, you call us. Not a reseller. Not a regional agent. Us.
Manufactured in Hosur, Tamil Nadu. Serviced locally. 2-year warranty backed by the manufacturer — not a distributor who may not be around in three years.
Specific wavelengths of near-infrared light penetrate tissue and trigger a cascade of beneficial cellular responses — without heat, drugs, or surgery.
Near-infrared light at 980nm penetrates deep into musculoskeletal tissue, reaching joints, tendons, and muscle — well beyond the reach of surface treatments.
Photoreceptors in the mitochondria absorb the light energy and begin producing more ATP — the fuel cells use to repair and regenerate.
The therapy triggers anti-inflammatory signalling, reduces oxidative stress, and increases local blood flow — all without pharmaceutical intervention.
Accelerated tissue repair, reduced pain, and improved range of motion are the measurable outcomes — documented in peer-reviewed literature across conditions.
We cite peer-reviewed research. We have not commissioned these studies. The evidence belongs to two decades of independent veterinary science.
A 2022 randomised, double-blind, placebo-controlled trial found PBM therapy outperformed meloxicam in dogs with hip OA. A separate RCT found 82% of dogs receiving PBM for elbow OA reduced their NSAID requirement — versus 0% in the sham group.
University of Tennessee researchers used a 980nm laser at 5 J/cm² on post-surgical wounds. Renwick et al. demonstrated significantly improved gait scores in dogs receiving laser therapy following tibial plateau levelling osteotomy.
Rico-Holgado et al. conducted the first placebo-controlled RCT on laser therapy's effect on bacterial load in canine wounds — finding decreased bacterial counts and improved wound scores with no adverse effects.
A 2023 systematic literature review (Millis and Bergh, Animals journal, University of Tennessee and Swedish University of Agricultural Sciences) reviewed 45 published veterinary studies and confirmed musculoskeletal conditions, wounds, and pain as primary indications.
Applicable across dogs, cats, and birds. Organised by clinical category.
Hip/joint OA, post-surgical recovery, spinal IVDD, soft tissue injuries
Acute and chronic wounds, lick granuloma, bite wounds, contaminated lacerations
Pyoderma, dermatitis, skin infections — documented in clinical studies
Post-extraction pain, gingival inflammation — supported by recent research
Mastitis treatment — a key application of the VetLase Pro handheld model
Otitis, chronic pain management — part of ongoing maintenance protocols
We are not saying imported devices are clinically inferior. We are pointing out the non-clinical costs that are rarely calculated at the time of purchase.
| VetLase | Typical Imported Device | |
|---|---|---|
| Price point | 3–5x lower for equivalent output | 3–5x higher |
| Clinical output | 980nm, Pulsed + CW, 6W or 15W | Comparable clinical output |
| Warranty | 2 years — manufacturer direct | Typically 1 year |
| Service & support | India-based — same-day response | International — weeks of lead time |
| Spare parts | Immediate local availability | Subject to import timelines |
| Distributor stability | Manufacturer-direct — permanent | Risk of change every 2–3 years |
| Interface | Single screen — assistant-operable | Multi-screen — training-intensive |
| Upgrade pathway | Pro → 6W → 15W (built-in) | Typically none |
Request a demo or ask our team any clinical or procurement question. We will come to you.